Drug Transporters. Группа авторов
Чтение книги онлайн.
Читать онлайн книгу Drug Transporters - Группа авторов страница 13
LIST OF CONTRIBUTORS
Jeffry Adiwidjaja, Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia
Lauren M. Aleksunes,Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ, USA
Suresh V. Ambudkar,Laboratory of Cell Biology, Transport Biochemistry Section, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
Ebehiremen N. Ayewoh,Department of Pharmaceutical Sciences, University of Maryland, Baltimore, MD, USA
Agnes Basseville,Bioinformatics Unit, Institut de Cancérologie de l'Ouest, Saint Herblain, France
Susan E. Bates,Division of Hematology/Oncology, Columbia University Medical Center, New York, NY, USA
Reina Bendayan,Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
Rajinder K. Bhardwaj,Integrated Drug Development, Cetera Strategic Consulting, Parsippany, NJ, USA
Kim L. R. Brouwer,Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Dina Buitrago,Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA, USA
Stephen M. Carl,Department Industrial and Physical Pharmacy, School of Pharmacy, Purdue University, West Lafayette, IN, USA; Discovery Pharmaceutics and Analytical Sciences, Bristol‐Myers Squibb Research Institute, Princeton, NJ, USA
Cindy H. Chau,Genitourinary Malignancies Branch, Molecular Pharmacology Section, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
Eugene C. Chen,Drug Metabolism and Pharmacokinetics, Genentech, South San Francisco, CA, USA
Ayman El‐Kattan,DMPK, IFM Therapeutics, Boston, MA, USA
Osatohanmwen Jessica Enogieru,Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA, USA; Pharmacokinetics and Drug Metabolism, Amgen Inc., South San Francisco, CA, USA
Melanie A. Felmlee,Department of Pharmaceutics and Medicinal Chemistry, Thomas J. Long School of Pharmacy, University of the Pacific, Stockton, CA, USA
William D. Figg,Genitourinary Malignancies Branch, Molecular Pharmacology Section, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
Azusa Futatsugi,Faculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan
Vadivel Ganapathy,Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX, USA
Kathleen M. Giacomini,Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA, USA
Rajgopal Govindarajan,Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH, USA
Jeffry C. Granados,Department of Bioengineering, University of California, San Diego, CA, USA
Olafur Gudmundsson,Discovery Pharmaceutics and Analytical Sciences, Bristol‐Myers Squibb Research Institute, Princeton, NJ, USA
Matthew D. Harwood,Simcyp Division, Certara UK Ltd., Sheffield, UK
Dea Herrera‐Ruiz,Facultad de Farmacia, Universidad Autónoma del Estado de Morelos, Cuernavaca, México
Robert S. Jones,Drug Metabolism and Pharmacokinetics, Genentech, South San Francisco, CA, USA
Melanie S. Joy,Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, CO, USA
Yukio Kato,Faculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan
Richard B. Kim,Departments of Medicine, Physiology & Pharmacology and Oncology, The University of Western Ontario, London, Ontario, Canada
Franziska Klein,Dr. Margarete Fischer‐Bosch Institute of Clinical Pharmacology, University of Tuebingen, Stuttgart, Germany; Cluster of Excellence iFIT (EXC2180) “Image‐Guided and Functionally Instructed Tumor Therapies”, University of Tuebingen, Tuebingen, Germany
Gregory T. Knipp,Department Industrial and Physical Pharmacy, School of Pharmacy, Purdue University, West Lafayette, IN, USA
Megan L. Koleske,Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA, USA
Deanna L. Kroetz,Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA, USA
Nisha V. Kwatra,Division of Inflammation and Immune Pharmacology, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA
Yurong Lai,Drug Metabolism, Gilead Sciences Inc., Foster City, CA, USA
Xiaomin Liang,Drug Metabolism, Gilead Sciences Inc., Foster City, CA, USA
Sabrina Lusvarghi,Laboratory of Cell Biology, Transport Biochemistry Section, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
Kazuya Maeda,Laboratory of Pharmaceutics, Kitasato University School of Pharmacy, Minato‐ku, Tokyo, Japan
Qingcheng Mao,Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, WA, USA
Yusuke Masuo,Faculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan
Marilyn E. Morris,Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA
Stephanie Mowery,Department Industrial and Physical Pharmacy, School of Pharmacy, Purdue University, West Lafayette, IN, USA; Novo Nordisk Research Center, Indianapolis. Inc., Biology Indianapolis, IN, USA
William A. Murphy,Division of Pharmacotherapy and Experimental Therapeutics,